Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07139769
RecruitingNCT07139769ClinicalTrials.gov record

Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

Caregiving for Cancer

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Interventional
Phase
Not applicable
Age range
18 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
48 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP (E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYAs with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer
  • Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer at the Mass General Brigham Cancer
  • Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer
  • English-speaking
  • Aged over 18 years

Exclusion Criteria:

-Active symptoms of psychosis or suicidal ideation that would preclude safe participation

Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not applicable
Masking
No masking
Psychosocial Intervention for Parental Caregivers of AYA with Cancer-open pilot study

The study team aims to evaluate the feasibility and acceptability of the adapted psychosocial intervention to 1) improve psychological resiliency to stress and 2) reduce symptoms of depression, anxiety, and post-traumatic stress among parental caregivers, through a single-arm open pilot trial of 32 parents.

Behavioral: Psychosocial Intervention for Parental Caregivers of AYA with Cancer

Psychosocial Intervention for Parental Caregivers of AYA with Cancer BEHAVIORAL

A new adaptation of an evidence-supported intervention, the SMART-3RP program, to address psychological symptoms and promote well-being among parental caregivers of AYA with cancer.

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll

Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)

Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.

Intervention Feasibility: Proportion of Participants Completing the Program

Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)

Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.

Intervention Acceptability

Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)

Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Mass General Brigham Cancer Institute at Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting
Zeba Ahmad, Ph.D.CONTACTzahmad7@gmail.com6317860403
Zeba N Ahmad, Ph.D.PRINCIPAL_INVESTIGATOR
View location on map ↗

Study team and timeline

Lead sponsor
Zeba Ahmad, Ph.D.
Study start
Oct 22, 2025 Actual
Primary completion
2027-03 Estimated
Study completion
2027-05 Estimated
First posted
Aug 24, 2025 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

Zeba N Ahmad, Ph.D.CONTACTzahmad2@mgh.harvard.edu16177241586
Katana Corning, B.A.CONTACTkcorning@mgh.harvard.edu6177247593
Official study title

The RAISE Study: Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026